{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T03:23:57Z","timestamp":1776223437161,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012496","name":"Lorestan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.micpath.2023.106300","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T20:48:53Z","timestamp":1691614133000},"page":"106300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring the role of tryptophanyl-tRNA synthetase and associations with inflammatory markers and clinical outcomes in COVID-19 patients: A case-control study"],"prefix":"10.1016","volume":"183","author":[{"given":"Nastaran","family":"Najimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Zahednasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Farahmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Fouladvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholam Reza","family":"Talei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnaz","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayyad","family":"Khanizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-8096","authenticated-orcid":false,"given":"Sajad","family":"Karampoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2023.106300_bib1","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1002\/jmv.27929","article-title":"Coronavirus disease 2019 (COVID\u201019) update: from metabolic reprogramming to immunometabolism","volume":"94","author":"Rudiansyah","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2023.106300_bib2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41598-021-04683-w","article-title":"Biomarker candidates for progression and clinical management of COVID-19-associated pneumonia at the time of admission","volume":"12","author":"Calvet","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2023.106300_bib3","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1002\/jmv.28000","article-title":"The deciphering of the immune cells and marker signature in COVID\u201019 pathogenesis: an update","volume":"94","author":"Jasim","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2023.106300_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2023.106300_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.micpath.2023.106300_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/all.14496","article-title":"Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID\u201019 patients","volume":"76","author":"Zhang","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.micpath.2023.106300_bib7","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2023.106300_bib8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"Grasselli","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.micpath.2023.106300_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106051","article-title":"Procalcitonin levels in COVID-19 patients","volume":"56","author":"Hu","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2023.106300_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107684","article-title":"A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19)","volume":"97","author":"Karampoor","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.micpath.2023.106300_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell discovery"},{"key":"10.1016\/j.micpath.2023.106300_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.micpath.2023.106300_bib13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2023.106300_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","article-title":"Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19","volume":"180","author":"Liang","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.micpath.2023.106300_bib15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2023.106300_bib16","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2023.106300_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03422-3","article-title":"Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study","volume":"25","author":"Monedero","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.micpath.2023.106300_bib18","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2023.106300_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2023.106300_bib20","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with Covid-19","volume":"383","author":"Stone","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2023.106300_bib21","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1093\/cid\/ciaa812","article-title":"Compassionate use of tocilizumab for treatment of SARS-CoV-2 pneumonia","volume":"71","author":"Jordan","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2023.106300_bib22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2023.106300_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2023.106300_bib24","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.3390\/ijms22094523","article-title":"Tryptophanyl-tRNA synthetase as a potential therapeutic target","volume":"22","author":"Ahn","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2023.106300_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01291-18","article-title":"Released tryptophanyl-tRNA synthetase stimulates innate immune responses against viral infection","volume":"93","author":"Lee","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2023.106300_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12912","article-title":"Intracellular innate immune receptors: life inside the cell","volume":"297","author":"Kanneganti","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micpath.2023.106300_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108185","article-title":"SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant","volume":"32","author":"Konno","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.micpath.2023.106300_bib28","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1074\/jbc.RA119.009584","article-title":"Matrix metalloproteinases inactivate the proinflammatory functions of secreted moonlighting tryptophanyl-tRNA synthetase","volume":"294","author":"Jobin","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2023.106300_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.191","article-title":"Secreted tryptophanyl-tRNA synthetase as a primary defense system against infection","volume":"2","author":"Ahn","year":"2016","journal-title":"Nature Microbiology"},{"key":"10.1016\/j.micpath.2023.106300_bib30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/IAI.02765-14","article-title":"Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera","volume":"83","author":"Ellis","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2023.106300_bib31","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2023.106300_bib32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3390\/v14030613","article-title":"Aminoacyl-tRNA synthetase: a non-negligible molecule in RNA viral infection","volume":"14","author":"Feng","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2023.106300_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.818297","article-title":"The landscape of aminoacyl-tRNA synthetases involved in severe acute respiratory syndrome coronavirus 2 infection","volume":"12","author":"Feng","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.micpath.2023.106300_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102823","article-title":"Multi-omics analysis of respiratory specimens characterizes baseline molecular determinants associated with SARS-CoV-2 outcome","volume":"24","author":"Maras","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.micpath.2023.106300_bib35","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jmv.23985","article-title":"Associations between human TRIM22 gene expression and the response to combination therapy with Peg\u2010IFN\u03b1\u20102a and ribavirin in Iranian patients with chronic hepatitis C","volume":"86","author":"Sadeghi","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2023.106300_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.micpath.2023.106300_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2023.106300_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijid.2020.05.105","article-title":"Clinical value of full-length tryptophanyl-tRNA synthetase for sepsis detection in critically ill patients\u2014a retrospective clinical assessment","volume":"97","author":"Choi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.micpath.2023.106300_bib39","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2023.106300_bib40","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2023.106300_bib41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2023.106300_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","article-title":"Alarmins: chemotactic activators of immune responses","volume":"17","author":"Oppenheim","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2023.106300_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs, and alarmins: all we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.micpath.2023.106300_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.it.2009.03.003","article-title":"Interleukin-33\u2013cytokine of dual function or novel alarmin?","volume":"30","author":"Haraldsen","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.micpath.2023.106300_bib45","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1478-3231.2012.02802.x","article-title":"IL\u201033 and HMGB 1 alarmins: sensors of cellular death and their involvement in liver pathology","volume":"32","author":"Arshad","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.micpath.2023.106300_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cyto.2010.02.021","article-title":"HMGB1, a potent proinflammatory cytokine in sepsis","volume":"51","author":"Huang","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.micpath.2023.106300_bib47","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3349\/ymj.2014.55.5.1165","article-title":"The role of high mobility group box 1 in innate immunity","volume":"55","author":"Lee","year":"2014","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.micpath.2023.106300_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059616","article-title":"Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia","volume":"8","author":"Mishra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2023.106300_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123573","article-title":"Alarmin function of galectin-9 in murine respiratory tularemia","volume":"10","author":"Steichen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2023.106300_bib50","article-title":"The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis","volume":"6","author":"Starke","year":"2021","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.micpath.2023.106300_bib51","first-page":"2643","article-title":"Age-related risk factors and complications of patients with COVID-19: a population-based retrospective study","author":"Zhang","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.micpath.2023.106300_bib52","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1038\/s41598-022-10344-3","article-title":"Risk factors for severe COVID-19 differ by age for hospitalized adults","volume":"12","author":"Molani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2023.106300_bib53","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/jmv.26826","article-title":"Role of Toll\u2010like receptors in the pathogenesis of COVID\u201019","volume":"93","author":"Khanmohammadi","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2023.106300_bib54","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.02.012","article-title":"Beyond empiricism: informing vaccine development through innate immunity research","volume":"148","author":"Levitz","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2023.106300_bib55","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/ijms23031716","article-title":"SARS-CoV-2-Specific immune response and the pathogenesis of COVID-19","volume":"23","author":"Gusev","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2023.106300_bib56","first-page":"831","article-title":"Inflammation in COVID-19: from pathogenesis to treatment","volume":"14","author":"Wong","year":"2021","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.micpath.2023.106300_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108192","article-title":"The role of lovastatin in the attenuation of COVID-19","volume":"101","author":"Karampoor","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.micpath.2023.106300_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108137","article-title":"A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19)","volume":"100","author":"Karampoor","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.micpath.2023.106300_bib59","doi-asserted-by":"crossref","first-page":"e2221","DOI":"10.1002\/rmv.2221","article-title":"C\u2010reactive protein as an effector molecule in Covid\u201019 pathogenesis","volume":"31","author":"Mosquera\u2010Sulbaran","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.micpath.2023.106300_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269005","article-title":"Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections\u2014a prospective cohort study","volume":"17","author":"Lampart","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2023.106300_bib61","article-title":"The role of IL-6 in coronavirus, especially in COVID-19","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2023.106300_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2023.106300_bib63","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2249.2008.03646.x","article-title":"Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"152","author":"Komatsuda","year":"2008","journal-title":"Clin. Exp. Immunol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023003339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023003339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:57:52Z","timestamp":1760111872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401023003339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":63,"alternative-id":["S0882401023003339"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106300","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of tryptophanyl-tRNA synthetase and associations with inflammatory markers and clinical outcomes in COVID-19 patients: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106300"}}